Opus Genetics, Inc. (IRD)

Opus Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	30.32	50.5	42.63	24.53	16.4
Short-Term Investments	0	0.02	0.05	0.22	-
Cash & Short-Term Investments	30.32	50.52	42.68	24.75	16.4
Cash Growth	-39.97%	18.35%	72.44%	50.94%	966.95%
Accounts Receivable	5.77	2.33	4.85	-	-
Receivables	5.77	2.33	4.85	-	-
Prepaid Expenses	0.52	1.1	1.37	1.24	1.24
Other Current Assets	-	-	0.08	0.07	0.03
Total Current Assets	36.61	53.95	48.99	26.07	17.67
Property, Plant & Equipment	0.25	-	0.01	0.01	0.01
Total Assets	36.86	53.95	48.99	26.08	17.68
Accounts Payable	3.15	2.15	1.07	1.58	1.21
Accrued Expenses	8.15	1.82	1.37	1.73	1.97
Short-Term Debt	-	-	-	0.54	-
Current Income Taxes Payable	-	-	0.32	-	-
Other Current Liabilities	0	0.07	-	-	-
Total Current Liabilities	11.3	4.04	2.75	3.86	3.19
Other Long-Term Liabilities	-	-	-	-	27.96
Total Liabilities	11.3	4.04	2.75	3.86	31.15
Common Stock	0	0	0	0	0
Additional Paid-In Capital	145.72	131.37	117.72	111.59	19.21
Retained Earnings	-139	-81.47	-71.48	-89.37	-32.68
Total Common Equity	6.72	49.91	46.24	22.22	-13.47
Shareholders' Equity	25.57	49.91	46.24	22.22	-13.47
Total Liabilities & Equity	36.86	53.95	48.99	26.08	17.68
Total Debt	-	-	-	0.54	-
Net Cash (Debt)	30.32	50.52	42.68	24.22	16.4
Net Cash Growth	-39.97%	18.35%	76.27%	47.66%	-
Net Cash Per Share	1.14	2.34	2.07	1.63	3.52
Filing Date Shares Outstanding	45.48	24.81	20.95	18.99	10.93
Total Common Shares Outstanding	31.57	23.98	20.86	18.85	10.88
Working Capital	25.32	49.91	46.23	22.21	14.48
Book Value Per Share	0.21	2.08	2.22	1.18	-1.24
Tangible Book Value	6.72	49.91	46.24	22.22	-13.47
Tangible Book Value Per Share	0.21	2.08	2.22	1.18	-1.24
Machinery	-	-	0.03	0.03	0.03

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q